Intercellular adhesion molecule 4 and ischemic stroke: a two-sample Mendelian randomization study
Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to inv...
Saved in:
| Published in | Thrombosis journal Vol. 21; no. 1; pp. 40 - 8 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
11.04.2023
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1477-9560 1477-9560 |
| DOI | 10.1186/s12959-023-00485-4 |
Cover
Loading…
| Abstract | Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes.
A total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes.
Genetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01-1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01-1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02-1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03-1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings.
We found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke. |
|---|---|
| AbstractList | Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes.BACKGROUNDExperimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes.A total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes.METHODSA total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes.Genetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01-1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01-1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02-1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03-1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings.RESULTSGenetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01-1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01-1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02-1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03-1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings.We found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke.CONCLUSIONSWe found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke. BackgroundExperimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes.MethodsA total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes.ResultsGenetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01–1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01–1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02–1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03–1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings.ConclusionsWe found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke. Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes. A total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes. Genetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01-1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01-1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02-1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03-1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings. We found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke. Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes. A total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes. Genetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01-1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01-1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02-1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03-1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings. We found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke. Background Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes. Methods A total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes. Results Genetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01-1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01-1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02-1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03-1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings. Conclusions We found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke. Keywords: Ischemic stroke, Intercellular adhesion molecule 4, Risk, Mendelian randomization Abstract Background Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the relationship between ICAM-4 and ischemic stroke were limited. Herein, we performed a two-sample Mendelian randomization (MR) analysis to investigate the associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and its subtypes. Methods A total of 11 single-nucleotide polymorphisms associated with ICAM-4 were selected as instrumental variables based on the genome-wide association studies (GWAS) with 3,301 European individuals. Summary-level data about ischemic stroke and its subtypes were obtained from the Multi-ancestry GWAS launched by the International Stroke Genetics Consortium. We used the inverse-variance weighted method followed by a series of sensitivity analyses to evaluate the associations of genetically determined ICAM-4 with the risks of ischemic stroke and its subtypes. Results Genetically determined higher ICAM-4 levels were significantly associated with increased risks of ischemic stroke (in the IVW method fitted to multiplicative random effects model: odds ratio [OR] per standard deviation [SD] increase, 1.04; 95% confidence interval [CI], 1.01–1.07; P = 0.006; in the IVW analysis with fixed effects model: OR per SD increase, 1.04; 95% CI, 1.01–1.07; P = 0.003) and cardioembolic stroke (in multiplicative random effects model: OR per SD increase, 1.08; 95% CI, 1.02–1.14; P = 0.004; in fixed effects model: OR per SD increase, 1.08; 95% CI, 1.03–1.13; P = 0.003). There was no association of ICAM-4 with the risks of large artery stroke and small vessel stroke. MR-Egger regression showed no directional pleiotropy for all associations, and the sensitivity analyses with different MR methods further confirmed these findings. Conclusions We found positive associations of genetically determined plasma ICAM-4 with the risks of ischemic stroke and cardioembolic stroke. Future studies are needed to explore the detailed mechanism and investigate the targeting effect of ICAM-4 on ischemic stroke. |
| ArticleNumber | 40 |
| Audience | Academic |
| Author | Sun, Lulu Zhu, Zhengbao Wang, Yu Jia, Yiming Yang, Pinni Liu, Fanghua Guo, Daoxia Zheng, Jin Shi, Mengyao |
| Author_xml | – sequence: 1 givenname: Lulu surname: Sun fullname: Sun, Lulu – sequence: 2 givenname: Daoxia surname: Guo fullname: Guo, Daoxia – sequence: 3 givenname: Yiming surname: Jia fullname: Jia, Yiming – sequence: 4 givenname: Mengyao surname: Shi fullname: Shi, Mengyao – sequence: 5 givenname: Pinni surname: Yang fullname: Yang, Pinni – sequence: 6 givenname: Yu surname: Wang fullname: Wang, Yu – sequence: 7 givenname: Fanghua surname: Liu fullname: Liu, Fanghua – sequence: 8 givenname: Zhengbao surname: Zhu fullname: Zhu, Zhengbao – sequence: 9 givenname: Jin surname: Zheng fullname: Zheng, Jin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37041579$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktv1DAUhSNURB_wB1igSGzYpNiO7ThsUFXxGKmIDaytG_tmxkNiD3YCKr8eZ6aUtkLIC1v2d499rs9pceSDx6J4Tsk5pUq-TpS1oq0IqytCuBIVf1ScUN40VSskObqzPi5OU9oSwljLxJPiuG4Ip6JpTwpY-QmjwWGYB4gl2A0mF3w5hgHNPGDJS_C2dMlscHSmTFMM3_BNCeX0M1QJxl1mPqG3ODjwZcxwGN0vmBaRNM32-mnxuIch4bOb-az4-v7dl8uP1dXnD6vLi6vKCMmnClVnO2HzCyWAUcISokTXdh1nAonsiZJGtIQpYIo2nWwVCM64aKhARpq6PitWB10bYKt30Y0Qr3UAp_cbIa41xMmZATUaqJlpCVoruUEBbSNlr3qDwGqQi9bbg9Zu7ka0Bv0UYbgnev_Eu41ehx-aEtJSIdus8OpGIYbvM6ZJj7mHuc3gMcxJM0UI5TI7yOjLB-g2zNHnXi1UTRquCP1LrSE7cL4P-WKziOqLhgtGRYYydf4PKg-7_F6OT-_y_r2CF3ed3lr8k5AMsANgYkgpYn-LUKKXGOpDDHWOod7HUC-W1IMi46Z9JvJz3PC_0t9aM9_4 |
| CitedBy_id | crossref_primary_10_1016_j_annepidem_2024_10_008 crossref_primary_10_1007_s12035_024_04580_z crossref_primary_10_31083_j_jin2304087 |
| Cites_doi | 10.1016/j.amjmed.2021.07.027 10.1038/s41588-018-0058-3 10.7554/eLife.34408 10.1002/eji.1830251217 10.1016/s1474-4422(21)00252-0 10.1161/01.str.24.1.35 10.1002/9780470743386 10.1055/s-0033-1363470 10.1074/jbc.M211282200 10.1201/9780429324352 10.1214/19-AOS1866 10.1016/s1474-4422(12)70234-x 10.1161/CIRCRESAHA.116.308427 10.1161/ATVBAHA.119.313055 10.1093/ije/dyt179 10.1002/ana.25916 10.1016/j.tracli.2006.02.022 10.3390/ijms21186454 10.1016/j.bbagen.2007.09.003 10.1371/journal.pone.0222362 10.1093/ije/dyv080 10.1007/s40471-017-0128-6 10.1136/bmj.k601 10.1016/s0140-6736(17)31928-1 10.1038/s41586-018-0175-2 10.1002/sim.6522 10.3174/ajnr.A6467 10.1182/blood.v98.2.458 10.1182/blood-2006-04-014878 10.1002/gepi.21758 10.1002/sim.3034 10.1002/sim.4197 10.1161/CIRCULATIONAHA.118.035905 10.1182/blood-2006-11-056101 10.1001/jama.2021.18236 10.1182/blood-2004-01-0042 10.1093/ije/dyr036 10.1002/1097-0258(20000715)19:13<1707::aid-sim491>3.0.co;2-p |
| ContentType | Journal Article |
| Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
| Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12959-023-00485-4 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1477-9560 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_eca32c90edd64ce5a9766f8fcea23a63 PMC10091569 A745215013 37041579 10_1186_s12959_023_00485_4 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 82103921 – fundername: China Postdoctoral Science Foundation grantid: 2021M690115 – fundername: ; grantid: 82103921 – fundername: ; grantid: 2021M690115 |
| GroupedDBID | --- 0R~ 29Q 2WC 53G 5VS 6PF 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFS ACIHN ACUHS ADBBV ADRAZ ADUKV AEAQA AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M48 M~E O5R O5S OK1 OVT PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP W2D WOQ WOW XSB ~8M -A0 3V. ACRMQ ADINQ C24 FRP NPM PMFND 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c564t-e8bdb5d2296aac85d0085b9bb425e06f086c59028a2817b698a54245715e20733 |
| IEDL.DBID | M48 |
| ISSN | 1477-9560 |
| IngestDate | Wed Aug 27 01:20:08 EDT 2025 Thu Aug 21 18:38:33 EDT 2025 Thu Jul 10 23:12:11 EDT 2025 Mon Jun 30 02:41:06 EDT 2025 Tue Jun 17 21:37:04 EDT 2025 Tue Jun 10 20:33:39 EDT 2025 Thu Jan 02 22:52:15 EST 2025 Thu Apr 24 23:09:06 EDT 2025 Tue Jul 01 04:21:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Risk Ischemic stroke Mendelian randomization Intercellular adhesion molecule 4 |
| Language | English |
| License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c564t-e8bdb5d2296aac85d0085b9bb425e06f086c59028a2817b698a54245715e20733 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2803074801?pq-origsite=%requestingapplication% |
| PMID | 37041579 |
| PQID | 2803074801 |
| PQPubID | 42867 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_eca32c90edd64ce5a9766f8fcea23a63 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10091569 proquest_miscellaneous_2800146424 proquest_journals_2803074801 gale_infotracmisc_A745215013 gale_infotracacademiconefile_A745215013 pubmed_primary_37041579 crossref_primary_10_1186_s12959_023_00485_4 crossref_citationtrail_10_1186_s12959_023_00485_4 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-04-11 |
| PublicationDateYYYYMMDD | 2023-04-11 |
| PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-11 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Thrombosis journal |
| PublicationTitleAlternate | Thromb J |
| PublicationYear | 2023 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | MJ Brion (485_CR24) 2013; 42 JMB Rees (485_CR31) 2019; 14 485_CR38 FA Spring (485_CR4) 2001; 15 A Toivanen (485_CR6) 2008; 1780 J Bowden (485_CR34) 2015; 44 E Di Angelantonio (485_CR20) 2017; 390 S Burgess (485_CR22) 2011; 40 MK Georgakis (485_CR13) 2019; 8 S Yuan (485_CR15) 2020; 88 EA Engels (485_CR29) 2000; 15 E Ihanus (485_CR5) 2007; 15 R Zennadi (485_CR35) 2007; 1 S Burgess (485_CR23) 2011; 20 485_CR26 DA Lawlor (485_CR11) 2008; 15 Y Choi (485_CR14) 2020; 40 NM Davies (485_CR12) 2018; 12 485_CR27 MF Greco (485_CR28) 2015; 20 S Burgess (485_CR25) 2013; 37 J Goebel (485_CR39) 2020; 41 VL Feigin (485_CR1) 2021; 20 P Hermand (485_CR7) 2003; 14 BB Sun (485_CR18) 2018; 558 J Zheng (485_CR16) 2017; 4 R Malik (485_CR19) 2018; 50 485_CR33 HP Adams Jr (485_CR21) 1993; 24 485_CR32 P Bailly (485_CR3) 1995; 25 M Delahunty (485_CR36) 2006; 13 X Hu (485_CR10) 2017; 3 M Traylor (485_CR37) 2012; 11 VX Du (485_CR8) 2014; 40 R Zennadi (485_CR9) 2004; 1 485_CR2 VW Skrivankova (485_CR17) 2021; 26 485_CR30 |
| References_xml | – ident: 485_CR2 doi: 10.1016/j.amjmed.2021.07.027 – volume: 50 start-page: 524 issue: 4 year: 2018 ident: 485_CR19 publication-title: Nat Genet Apr doi: 10.1038/s41588-018-0058-3 – ident: 485_CR32 doi: 10.7554/eLife.34408 – volume: 25 start-page: 3316 issue: 12 year: 1995 ident: 485_CR3 publication-title: Eur J Immunol Dec doi: 10.1002/eji.1830251217 – volume: 20 start-page: 795 issue: 10 year: 2021 ident: 485_CR1 publication-title: Lancet Neurol doi: 10.1016/s1474-4422(21)00252-0 – volume: 24 start-page: 35 issue: 1 year: 1993 ident: 485_CR21 publication-title: Stroke Jan doi: 10.1161/01.str.24.1.35 – ident: 485_CR26 doi: 10.1002/9780470743386 – volume: 40 start-page: 72 issue: 1 year: 2014 ident: 485_CR8 publication-title: Semin Thromb Hemost Feb doi: 10.1055/s-0033-1363470 – ident: 485_CR30 – volume: 14 start-page: 4892 issue: 7 year: 2003 ident: 485_CR7 publication-title: J Biol Chem Feb doi: 10.1074/jbc.M211282200 – ident: 485_CR27 doi: 10.1201/9780429324352 – ident: 485_CR33 doi: 10.1214/19-AOS1866 – volume: 11 start-page: 951 issue: 11 year: 2012 ident: 485_CR37 publication-title: Lancet Neurol doi: 10.1016/s1474-4422(12)70234-x – volume: 3 start-page: 449 issue: 3 year: 2017 ident: 485_CR10 publication-title: Circ Res Feb doi: 10.1161/CIRCRESAHA.116.308427 – volume: 40 start-page: 437 issue: 2 year: 2020 ident: 485_CR14 publication-title: Arterioscler Thromb Vasc Biol Feb doi: 10.1161/ATVBAHA.119.313055 – volume: 42 start-page: 1497 issue: 5 year: 2013 ident: 485_CR24 publication-title: Int J Epidemiol Oct doi: 10.1093/ije/dyt179 – volume: 88 start-page: 1229 issue: 6 year: 2020 ident: 485_CR15 publication-title: Ann Neurol Dec doi: 10.1002/ana.25916 – volume: 13 start-page: 44 issue: 1–2 year: 2006 ident: 485_CR36 publication-title: Transfus Clin Biol Mar-Apr doi: 10.1016/j.tracli.2006.02.022 – ident: 485_CR38 doi: 10.3390/ijms21186454 – volume: 1780 start-page: 456 issue: 3 year: 2008 ident: 485_CR6 publication-title: Biochim Biophys Acta Mar doi: 10.1016/j.bbagen.2007.09.003 – volume: 14 start-page: e0222362 issue: 9 year: 2019 ident: 485_CR31 publication-title: PLoS ONE doi: 10.1371/journal.pone.0222362 – volume: 44 start-page: 512 issue: 2 year: 2015 ident: 485_CR34 publication-title: Int J Epidemiol Apr doi: 10.1093/ije/dyv080 – volume: 4 start-page: 330 issue: 4 year: 2017 ident: 485_CR16 publication-title: Curr Epidemiol Rep doi: 10.1007/s40471-017-0128-6 – volume: 12 start-page: k601 year: 2018 ident: 485_CR12 publication-title: BMJ Jul doi: 10.1136/bmj.k601 – volume: 390 start-page: 2360 issue: 10110 year: 2017 ident: 485_CR20 publication-title: The Lancet doi: 10.1016/s0140-6736(17)31928-1 – volume: 558 start-page: 73 issue: 7708 year: 2018 ident: 485_CR18 publication-title: Nat Jun doi: 10.1038/s41586-018-0175-2 – volume: 20 start-page: 2926 issue: 21 year: 2015 ident: 485_CR28 publication-title: Stat Med Sep doi: 10.1002/sim.6522 – volume: 41 start-page: 650 issue: 4 year: 2020 ident: 485_CR39 publication-title: AJNR Am J Neuroradiol Apr doi: 10.3174/ajnr.A6467 – volume: 15 start-page: 458 issue: 2 year: 2001 ident: 485_CR4 publication-title: Blood Jul doi: 10.1182/blood.v98.2.458 – volume: 15 start-page: 802 issue: 2 year: 2007 ident: 485_CR5 publication-title: Blood Jan doi: 10.1182/blood-2006-04-014878 – volume: 37 start-page: 658 issue: 7 year: 2013 ident: 485_CR25 publication-title: Genet Epidemiol Nov doi: 10.1002/gepi.21758 – volume: 15 start-page: 1133 issue: 8 year: 2008 ident: 485_CR11 publication-title: Stat Med Apr doi: 10.1002/sim.3034 – volume: 20 start-page: 1312 issue: 11 year: 2011 ident: 485_CR23 publication-title: Stat Med May doi: 10.1002/sim.4197 – volume: 8 start-page: 256 issue: 2 year: 2019 ident: 485_CR13 publication-title: Circulation Jan doi: 10.1161/CIRCULATIONAHA.118.035905 – volume: 1 start-page: 2708 issue: 7 year: 2007 ident: 485_CR35 publication-title: Blood Oct doi: 10.1182/blood-2006-11-056101 – volume: 26 start-page: 1614 issue: 16 year: 2021 ident: 485_CR17 publication-title: JAMA Oct doi: 10.1001/jama.2021.18236 – volume: 1 start-page: 3774 issue: 12 year: 2004 ident: 485_CR9 publication-title: Blood Dec doi: 10.1182/blood-2004-01-0042 – volume: 40 start-page: 755 issue: 3 year: 2011 ident: 485_CR22 publication-title: Int J Epidemiol Jun doi: 10.1093/ije/dyr036 – volume: 15 start-page: 1707 issue: 13 year: 2000 ident: 485_CR29 publication-title: Stat Med Jul doi: 10.1002/1097-0258(20000715)19:13<1707::aid-sim491>3.0.co;2-p |
| SSID | ssj0022925 |
| Score | 2.305578 |
| Snippet | Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based evidence on the... Background Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based... BackgroundExperimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the population-based... Abstract Background Experimental studies suggested that intercellular adhesion molecule 4 (ICAM-4) might be implicated in ischemic stroke, but the... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 40 |
| SubjectTerms | Blood & organ donations Consortia Estimates Genetic aspects Genomes Genomics Intercellular adhesion molecule 4 Ischemia Ischemic stroke Maximum likelihood method Mendelian randomization Plasma Risk Single nucleotide polymorphisms Statistical power Stroke Stroke (Disease) Thrombosis |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEB-kB_Ei1s-1VSIIHiT07W6STbxVsRThebLQW8jX0qLdlb4t_vvOZPMebxH04vUlC5v5ePOb2clvAN72dR9ErQPXSmOC0qIuXCcCb2OvtOyCdy3dd15_VecX4sulvNwb9UU9YTM98Cy4kxRc2wSzSjEqEZJ0GD9Vr_uQXNM6lXk-MeZtk6mSajWmkdsrMlqdbDCqScMxPnEyWcnFIgxltv4__5P3gtKyYXIvAp09gocFOrLT-ZUP4V4aHsP9dfk4_gRcru5RJZ5aS5mLV4lKYexmnoCbmGBuiOwa81nqiGeb6Xb8nj4wx6ZfI9844glmayqJU-mDYRCL4025pskyDe1TuDj7_O3TOS8TFHiQSkw8aR-9jCgO5VzQMhLC8sZ79NS0Uj3mMyHzt7hG151XRjtJn0K7WqaGxjk-g4NhHNILYIrGVCO2Sp4mzctoEElIqU3ScoVy0RXUW4HaUOjFacrFD5vTDK3srASLSrBZCVZU8H73zM-ZXOOvuz-SnnY7iRg7_4DmYou52H-ZSwXvSMuW3BdfL7hyCwEPSURY9rQTCGgkAuMKjhc70e3CcnlrJ7a4_cbSqC_EZBj1K3izW6YnqZVtSONd3kOEPSjmCp7PZrU7UtsRY0JnKtALg1ucebkyXF9lUvAawTLm4ubl_5DSETxosrMIXtfHcDDd3qVXCL4m_zr72W-BdCst priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7aFEovpe-6TYsKhR6KyNqWZLmXkISEUNieGtibkCW5CWnsdO3Qv98ZWbuJKeRqSWBpZjQPzXwD8LnNWydy7bhWGh2UEmlhK-F46VulZeUaW1K98_KHOj0T31dylQJuQ0qr3NyJ8aL2vaMY-R51UUJ1hxfq_vUfTl2j6HU1tdB4CI8Iuoycr2p163AVdSE3hTJa7Q2o22TNUUtxYlzJxUwZRcz-_2_mO6ppnjZ5Rw-dPIOnyYBkBxPFn8OD0L2Ax8v0RP4SbIzxUTyeEkyZ9eeBAmLsauqDG5hgtvPsAr1ayotnw7juL8M3Ztn4t-eDJbRgtqTAOAVAGKoy31-lYk0WwWhfwdnJ8c-jU576KHAnlRh50I1vpMfjUNY6LT3ZWU3dNCivYaFa9GpcRHGxhc6rRtXaSnoQrXIZCmrq-Bp2ur4Lb4EpalaNFlZoqN-89DXaE1LqOmi5wHPRGeSbAzUugYxTr4vfJjobWpmJCAaJYCIRjMjg63bN9QSxce_sQ6LTdibBY8cP_fqXSdJmgrNl4epF8F4JF6RFo0u1unXBFqVVZQZfiMqGhBh_z9lUi4CbJDgsc1AJNGskmscZ7M5movC5-fCGT0wS_sHcsmoGn7bDtJIS2rrQ38Q5BNuDx5zBm4mttlsqK8JNqOoM9IzhZnuej3QX5xEaPEeTGT3y-t39__UenhRRDATP813YGdc34QMaV2PzMUrQP0buIPs priority: 102 providerName: ProQuest |
| Title | Intercellular adhesion molecule 4 and ischemic stroke: a two-sample Mendelian randomization study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37041579 https://www.proquest.com/docview/2803074801 https://www.proquest.com/docview/2800146424 https://pubmed.ncbi.nlm.nih.gov/PMC10091569 https://doaj.org/article/eca32c90edd64ce5a9766f8fcea23a63 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEB_uA8QX8dvquUQQfJDqtk3SVBC5lTsOYQ85XFh8CWmS3h3etbrbQ_3vnUm75YqH-LIPTbps5mPnN5NkfgAvq6SyPFE2VlJhgpKhLkzObZy5SiqR29JkdN95fiyPFvzTUiy3YEN31AtwfWNqR3xSi9XFm18_fn9Ah38fHF7Jt2uMWaKIMfrEZJAi5tuwi5EpJyqHOR92FdK0CCSsCQ_blnK6uURz43eMAlXo5__3v_a1sDU-UnktRh3ehTs9uGT7nTXcgy1f34db8377_AGYUP-jWj0dPmXGnXkqlrHLjiPXM85M7dg5ioXOzLN1u2q--XfMsPZnE68NdRJmcyqaU3GEYZhzzWV_kZOFRrUPYXF48OXjUdxzLMRWSN7GXpWuFA5FI42xSjjCYGVRlujLfiorzHhs6PBiUpXkpSyUEbRZmifCp0T4-Ah26qb2T4BJIrJG9OVL4qIXrkCsIYQqvBJTlIuKINkIVNu-ATnxYFzokIgoqTslaFSCDkrQPILXwzvfu_Yb_5w9Iz0NM6l1dnjQrE5174naW5Oltph65yS3XhgEZLJSlfUmzYzMInhFWtZkcvjzrOnvKeAiqVWW3s85Qh6B0DmCvdFMdEw7Ht7Yid7YtSYyMERtiAsieDEM05t02K32zVWYQy19UMwRPO7MalhSllNPhbyIQI0MbrTm8Uh9fhbahicIpzFbL57-9wKfwe00eASPk2QPdtrVlX-OGKwtJ7CdL_MJ7M4Ojj-fTEIlYxKcDT9PZl__ADziLrg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwE4oCibpzYcZAQaqHVlnZXCLVSb65jO7SCJmU3VcWf4jcyk8fSCKm3XmMnij2vb8aeGYDXRVTYJFI2VFKhgxIjLUya2DB2hVQitbmJKd95OpOTg-TLoThcgT99Lgxdq-x1YqOoXWUpRr5OXZTQ3KFC_Xj2K6SuUXS62rfQaNli1_--QJdt8WHnM9L3DefbW_ufJmHXVSC0QiZ16FXucuE4z6QxVglHqCPP8hy5149lgRjfNjVNDFdRmstMGUHHg2kkPKcWh_jdG7CaxAgVRrC6uTX7-m3p4vGMiz41R8n1BVpTkYVoF0MSFREmA_PXdAn43xZcMobDi5qXLN_2XbjTQVa20fLYPVjx5X24Oe0O5R-AaaKKdAJAV1qZcceeQnDstO2861nCTOnYCfrRdBOfLep59cO_Z4bVF1W4MFSfmE0pFE8hF4bG01WnXXooa8rfPoSDa9njRzAqq9I_ASapPTZiOp9Th3vhMkQwQqjMKzHGfVEBRP2GatuVNafuGj91494oqVsiaCSCboigkwDeLd85a4t6XDl7k-i0nEkFuZsH1fy77uRbe2tibrOxd04m1guDME8WqrDe8NjIOIC3RGVNagN_z5ou-wEXSQW49EaaIJASCMgDWBvMRHG3w-GeT3Snbhb6n3AE8Go5TG_SFbrSV-fNHCoUhNscwOOWrZZLilOq1JBmAagBww3WPBwpT46bYuQRgvRIyOzp1f_1Em5N9qd7em9ntvsMbvNGJJIwitZgVM_P_XOEdnX-opMnBkfXLcJ_AazNXSo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intercellular+adhesion+molecule+4+and+ischemic+stroke%3A+a+two-sample+Mendelian+randomization+study&rft.jtitle=Thrombosis+journal&rft.au=Sun%2C+Lulu&rft.au=Guo%2C+Daoxia&rft.au=Jia%2C+Yiming&rft.au=Shi%2C+Mengyao&rft.date=2023-04-11&rft.pub=BioMed+Central+Ltd&rft.issn=1477-9560&rft.eissn=1477-9560&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1186%2Fs12959-023-00485-4&rft.externalDocID=A745215013 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-9560&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-9560&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-9560&client=summon |